# Caribou Biosciences, Inc.: filings

CRBU · Nasdaq · CIK 1619856 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/crbu.md) · [Financials](/companies/crbu/financials.md) · [Filings](/companies/crbu/filings.md) · [Insiders](/companies/crbu/insiders.md)

## Reports and events: 109 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 97, 8-K 71, 3 20, 10-Q 16, SC 13G/A 12, DEFA14A 8, SC 13G 7, CORRESP 6, S-8 6, 10-K 5, DEF 14A 5, 8-K/A 4, ARS 4, UPLOAD 4, 144 3, D 3, EFFECT 3, 10-Q/A 2, 424B5 2, 4/A 2, PRE 14A 2, S-1/A 2, S-3 2, SEC STAFF LETTER 2, 3/A 1, 424B4 1, 5 1, 8-A12B 1, CERT 1, D/A 1, DEFR14A 1, DRS 1, DRS/A 1, DRSLTR 1, FWP 1, S-1 1, S-1MEF 1, SC 13D 1, SC 13D/A 1, SCHEDULE 13D 1, SCHEDULE 13G/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-06 | 20:07 ET | [8-K](/filings/0001193125-26-415559.md) | 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-415559 |
| 2026-08-13 | 20:11 ET | [10-Q](/filings/0001619856-26-000055.md) | Quarterly report, period 2026-06-30 | 0001619856-26-000055 |
| 2026-08-13 | 20:07 ET | [8-K](/filings/0001619856-26-000053.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001619856-26-000053 |
| 2026-06-18 | 20:02 ET | [8-K](/filings/0001619856-26-000047.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001619856-26-000047 |
| 2026-06-11 | 12:02 ET | [8-K](/filings/0001619856-26-000043.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001619856-26-000043 |
| 2026-05-07 | 20:14 ET | [10-Q](/filings/0001619856-26-000036.md) | Quarterly report, period 2026-03-31 | 0001619856-26-000036 |
| 2026-05-07 | 20:10 ET | [8-K](/filings/0001619856-26-000035.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001619856-26-000035 |
| 2026-04-24 | 20:01 ET | [DEF 14A](/filings/0001619856-26-000022.md) | Proxy statement, period 2025-12-31 | 0001619856-26-000022 |
| 2026-03-31 | 12:02 ET | [8-K](/filings/0001619856-26-000012.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001619856-26-000012 |
| 2026-03-05 | 21:09 ET | [10-K](/filings/0001619856-26-000008.md) | Annual report, period 2025-12-31 | 0001619856-26-000008 |
| 2026-03-05 | 21:07 ET | [8-K](/filings/0001619856-26-000007.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001619856-26-000007 |
| 2025-11-12 | 21:09 ET | [10-Q](/filings/0001619856-25-000071.md) | Quarterly report, period 2025-09-30 | 0001619856-25-000071 |
| 2025-11-12 | 21:08 ET | [8-K](/filings/0001619856-25-000070.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001619856-25-000070 |
| 2025-11-03 | 12:02 ET | [8-K](/filings/0001619856-25-000065.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001619856-25-000065 |
| 2025-08-12 | 20:09 ET | [10-Q](/filings/0001619856-25-000061.md) | Quarterly report, period 2025-06-30 | 0001619856-25-000061 |
| 2025-08-12 | 20:07 ET | [8-K](/filings/0001619856-25-000060.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001619856-25-000060 |
| 2025-06-23 | 12:02 ET | [8-K](/filings/0001619856-25-000052.md) | 8.01 Other events | 0001619856-25-000052 |
| 2025-06-13 | 20:02 ET | [8-K](/filings/0001619856-25-000047.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001619856-25-000047 |
| 2025-05-08 | 20:19 ET | [10-Q](/filings/0001619856-25-000043.md) | Quarterly report, period 2025-03-31 | 0001619856-25-000043 |
| 2025-05-08 | 20:06 ET | [8-K](/filings/0001619856-25-000040.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001619856-25-000040 |
| 2025-04-25 | 20:40 ET | [SCHEDULE 13D](/filings/0000950170-25-058810.md) | Ownership report, active investor | 0000950170-25-058810 |
| 2025-04-25 | 20:02 ET | [DEF 14A](/filings/0001619856-25-000031.md) | Proxy statement, period 2024-12-31 | 0001619856-25-000031 |
| 2025-04-24 | 20:17 ET | [8-K](/filings/0001619856-25-000023.md) | 2.02 Results of operations; 2.05 Exit or disposal costs; 8.01 Other events; 9.01 Financial statements and exhibits | 0001619856-25-000023 |
| 2025-03-10 | 20:09 ET | [10-K](/filings/0001619856-25-000015.md) | Annual report, period 2024-12-31 | 0001619856-25-000015 |
| 2025-03-10 | 20:08 ET | [8-K](/filings/0001619856-25-000014.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001619856-25-000014 |
| 2025-01-13 | 13:00 ET | [8-K](/filings/0001619856-25-000006.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001619856-25-000006 |
| 2025-01-02 | 13:03 ET | [8-K](/filings/0001619856-25-000002.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001619856-25-000002 |
| 2024-12-06 | 21:06 ET | [SC 13D/A](/filings/0001193125-24-272453.md) | Ownership report, active investor, amended | 0001193125-24-272453 |
| 2024-11-06 | 21:08 ET | [10-Q](/filings/0001619856-24-000081.md) | Quarterly report, period 2024-09-30 | 0001619856-24-000081 |
| 2024-11-06 | 21:07 ET | [8-K](/filings/0001619856-24-000080.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001619856-24-000080 |
| 2024-09-27 | 20:02 ET | [8-K/A](/filings/0001619856-24-000074.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001619856-24-000074 |
| 2024-09-03 | 20:01 ET | [8-K](/filings/0001619856-24-000071.md) | 5.02 Departure or appointment of officers or directors | 0001619856-24-000071 |
| 2024-08-12 | 12:03 ET | [8-K](/filings/0001619856-24-000068.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001619856-24-000068 |
| 2024-08-06 | 20:08 ET | [10-Q](/filings/0001619856-24-000064.md) | Quarterly report, period 2024-06-30 | 0001619856-24-000064 |
| 2024-08-06 | 20:07 ET | [8-K](/filings/0001619856-24-000063.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001619856-24-000063 |
| 2024-07-16 | 20:01 ET | [8-K](/filings/0001619856-24-000054.md) | 2.02 Results of operations; 2.05 Exit or disposal costs; 9.01 Financial statements and exhibits | 0001619856-24-000054 |
| 2024-06-14 | 20:03 ET | [8-K](/filings/0001619856-24-000050.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001619856-24-000050 |
| 2024-06-03 | 10:01 ET | [8-K](/filings/0001619856-24-000046.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001619856-24-000046 |
| 2024-05-07 | 20:15 ET | [10-Q](/filings/0001619856-24-000038.md) | Quarterly report, period 2024-03-31 | 0001619856-24-000038 |
| 2024-05-07 | 20:11 ET | [8-K](/filings/0001619856-24-000036.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001619856-24-000036 |
| 2024-04-25 | 20:02 ET | [DEF 14A](/filings/0001619856-24-000026.md) | Proxy statement, period 2023-12-31 | 0001619856-24-000026 |
| 2024-04-04 | 20:05 ET | [8-K](/filings/0001619856-24-000018.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001619856-24-000018 |
| 2024-03-11 | 20:25 ET | [10-K](/filings/0001619856-24-000013.md) | Annual report, period 2023-12-31 | 0001619856-24-000013 |
| 2024-03-11 | 20:22 ET | [8-K](/filings/0001619856-24-000012.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001619856-24-000012 |
| 2024-01-08 | 13:00 ET | [8-K](/filings/0001619856-24-000003.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001619856-24-000003 |
| 2023-12-22 | 21:05 ET | [8-K](/filings/0001619856-23-000138.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001619856-23-000138 |
| 2023-12-12 | 21:05 ET | [8-K](/filings/0001619856-23-000134.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001619856-23-000134 |
| 2023-11-17 | 21:06 ET | [10-Q/A](/filings/0001619856-23-000130.md) | Quarterly report, amended, period 2023-06-30 | 0001619856-23-000130 |
| 2023-11-17 | 21:05 ET | [10-Q/A](/filings/0001619856-23-000129.md) | Quarterly report, amended, period 2023-03-31 | 0001619856-23-000129 |
| 2023-11-07 | 21:03 ET | [10-Q](/filings/0001619856-23-000124.md) | Quarterly report, period 2023-09-30 | 0001619856-23-000124 |

Page 1 of 3. [Older](/companies/crbu/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.